TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PLRX

Pliant Therapeutics Inc

Healthcare · Biotechnology

1.00$ -1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Pliant Therapeutics Inc (PLRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 190 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLRX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
540 512 522 484 446 397 345 300 277 225 203 190
534 506 490 448 410 362 311 267 246 196 175 163
58 63 114 80 80 71 92 87 94 45 22 25
524 494 482 437 405 356 306 263 242 191 171 158
2.1 3.0 2.3 2.8 2.2 2.3 1.7 1.5 0.9 0.8 0.9 0.9
7.9 – – – – – – – – – – –
37 39 84 91 100 93 88 80 76 44 37 43
27 29 30 31 40 33 28 21 18 16 10 16
2.1 1.3 0.8 0.1 0.3 0.5 0.8 1.2 1.2 1.4 1.7 2.3
3.4 4.5 7.3 3.2 6.9 6.0 5.6 1.4 0.5 0.5 0.4 1.5
10 10 30 30 30 30 30 30 30 – – –
503 474 437 393 346 304 257 220 200 181 165 147
-459 -500 -547 -603 -660 -710 -766 -810 -836 -859 -879 -902
60 60 60 60 61 61 61 61 61 61 62 62

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?